Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Intec Pharma Ord Shr (NTEC)

Intec Pharma Ord Shr (NTEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,757
  • Shares Outstanding, K 3,592
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,130 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NTEC with:

Options Overview

Details
  • Implied Volatility 0.00%
  • Historical Volatility 71.27%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 957.97% on 11/18/20
  • IV Low 0.00% on 04/16/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 2,223
  • Open Int (30-Day) 451

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -1.08
  • Number of Estimates 1
  • High Estimate -1.08
  • Low Estimate -1.08
  • Prior Year -1.60
  • Growth Rate Est. (year over year) +32.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.66 +4.64%
on 03/25/21
5.16 -25.78%
on 03/17/21
-1.24 (-24.38%)
since 03/16/21
3-Month
3.25 +17.85%
on 03/05/21
9.20 -58.37%
on 02/11/21
-0.30 (-7.26%)
since 01/15/21
52-Week
2.20 +74.09%
on 10/30/20
15.82 -75.78%
on 07/22/20
-0.72 (-15.86%)
since 04/16/20

Most Recent Stories

More News
Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc.

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, today...

GSK : 37.75 (+0.16%)
NTEC : 3.83 (-3.28%)
BTX : 7.94 (+25.24%)
MYGN : 27.31 (-5.04%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates LEAF, MFNC, PMBC, NTEC; Shareholders are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

LEAF : 9.06 (-0.98%)
MFNC : 21.14 (-0.42%)
PMBC : 8.93 (+0.56%)
NTEC : 3.83 (-3.28%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of NTEC, MLND, CTAC, and ATH Mergers

Rigrodsky Law, P.A. announces that it is investigating:

NTEC : 3.83 (-3.28%)
MLND : 0.9900 (-4.35%)
CTAC : 9.90 (unch)
ATH : 55.45 (+2.42%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds KSU, SNX, SPRT, and NTEC Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

KSU : 257.51 (-0.44%)
SNX : 123.96 (+2.23%)
SPRT : 3.81 (-12.01%)
NTEC : 3.83 (-3.28%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates COHR, JCS, NTEC, KSU; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

IIVI : 81.42 (-0.31%)
COHR : 268.04 (+0.16%)
JCS : 5.75 (-2.71%)
NTEC : 3.83 (-3.28%)
KSU : 257.51 (-0.44%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds SNX, SPRT, NTEC, and PMBC Shareholders About Its Ongoing Investigations

, /PRNewswire/ -- 

SNX : 123.96 (+2.23%)
SPRT : 3.81 (-12.01%)
NTEC : 3.83 (-3.28%)
PMBC : 8.93 (+0.56%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates SNX, NTEC, STAY; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

SNX : 123.96 (+2.23%)
NTEC : 3.83 (-3.28%)
STAY : 19.70 (-0.51%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds KSU, SNX, SPRT, and NTEC Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

KSU : 257.51 (-0.44%)
SNX : 123.96 (+2.23%)
SPRT : 3.81 (-12.01%)
NTEC : 3.83 (-3.28%)
Halper Sadeh LLP Investigates the Following Mergers - CLGX, SNX, ATH, RMBL, CTB, GNMK, NTEC; Shareholders are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CLGX : 79.88 (+0.06%)
SNX : 123.96 (+2.23%)
ATH : 55.45 (+2.42%)
RMBL : 37.59 (-0.24%)
CTB : 57.09 (-0.30%)
GNMK : 24.01 (+0.08%)
NTEC : 3.83 (-3.28%)
Lifshitz Law Firm, P.C. Announces Investigation of STAY, FI, GNMK, and NTEC

NEW YORK, NY / ACCESSWIRE / March 28, 2021 /

STAY : 19.70 (-0.51%)
FI : 3.35 (-4.56%)
GNMK : 24.01 (+0.08%)
NTEC : 3.83 (-3.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Its product candidates in clinical trial stages consists of Accordion Pill Carbidopa/Levodopa developed for the indication of treatment of Parkinson's disease...

See More

Key Turning Points

3rd Resistance Point 4.25
2nd Resistance Point 4.16
1st Resistance Point 3.99
Last Price 3.83
1st Support Level 3.73
2nd Support Level 3.64
3rd Support Level 3.47

See More

52-Week High 15.82
Fibonacci 61.8% 10.61
Fibonacci 50% 9.01
Fibonacci 38.2% 7.40
Last Price 3.83
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar